about
Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathyMechanotransduction in intervertebral discsInfluence of a constitutive increase in myofilament Ca(2+)-sensitivity on Ca(2+)-fluxes and contraction of mouse heart ventricular myocytesExperimental therapies in hypertrophic cardiomyopathyDifferential methylation of CpG sites in two isoforms of myosin binding protein C, an important hypertrophic cardiomyopathy gene.Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy.Strong cross-bridges potentiate the Ca(2+) affinity changes produced by hypertrophic cardiomyopathy cardiac troponin C mutants in myofilaments: a fast kinetic approach.Hypertrophic cardiomyopathy in young Maine Coon cats caused by the p.A31P cMyBP-C mutation--the clinical significance of having the mutation.Signaling and myosin-binding protein C.Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptorLeft ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonanceHuman molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy.Master redox regulator Trx1 upregulates SMYD1 & modulates lysine methylation.Mechanotransduction gone awry.Electromechanical relationship in hypertrophic cardiomyopathyContemporary treatment of hypertrophic cardiomyopathyCritical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection.Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms.Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitorsPopulation-based studies of myocardial hypertrophy: high resolution cardiovascular magnetic resonance atlases improve statistical power.Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.Animal models of arrhythmogenic cardiomyopathy.Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.Genetic test for dilated and hypertrophic cardiomyopathies: useful or less than useful for patients?Experimental models of inherited cardiomyopathy and its therapeutics.Analysis of selected genes associated with cardiomyopathy by next-generation sequencing.Animal Models of Congenital Cardiomyopathies Associated With Mutations in Z-Line Proteins.Next generation sequencing in research and diagnostics of ocular birth defects.Update on hypertrophic cardiomyopathy.Stressing the giant: a new approach to understanding dilated cardiomyopathy.TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection.Drosophila in the Heart of Understanding Cardiac Diseases: Modeling Channelopathies and Cardiomyopathies in the Fruitfly.Developmental cardiac hypertrophy in a mouse model of prolidase deficiency.
P2860
Q28242903-CA90968D-4A2F-4C30-8742-ED6E1420F870Q28543051-B1337916-39CE-4FA5-8B8C-75B0222E244EQ33707376-C5E30072-4013-4E08-A637-5B111E62A3C9Q33997765-26A5FA0F-6F93-4F12-B8FA-9FFB68423FE3Q34133294-321B251B-F407-4DDC-A3EF-F5BF89E59CF3Q34474908-CEC721A3-4D93-4A48-8AED-99876A6F2C30Q34488809-FDBE203A-E63F-487C-BED7-20683A89412AQ34600695-F964949E-E804-484B-940C-72C4285821BFQ34696154-E8FF716A-521B-4955-A782-F6F81C020517Q34759446-8C2A26F9-BB8A-4F03-A087-BA7ED6CE944FQ34973594-6823EFF8-0F14-4976-A6C4-DCF1163B504CQ36278641-BF74E746-29BF-430E-9279-BF6BE873B11BQ36350821-00C41B57-F2AD-4B02-BB2F-5A95170CD3C5Q36486897-27AC7534-E48F-4E3C-AB00-8D2D8FF932C5Q37158222-48259431-FA15-4782-8E8A-2DED2AD2F949Q37189079-50F22A7C-FF87-4C76-89C5-499896A36441Q37227838-EAA136EE-CE8C-43AD-84AD-FE361F20DFC0Q37373747-CB037626-FEE1-44E3-8FC9-694C6150A739Q37413082-3D7E3EEA-3ED5-4082-904A-64CA233BA96CQ37510643-043361AB-545F-4908-A2E4-FA0052893C61Q37557745-26CA1BEB-2DAC-4B62-9BEE-3E5580D6163DQ37609685-4F5D1B8D-9F43-426F-B8D8-6CAFEE37CB12Q37628322-DF1AA254-B45F-4411-9E31-A7F14E69C034Q37786123-2492F453-09E6-4142-85DD-8FE59C16211EQ38125689-AB550A3F-B88F-4560-9A45-6BFECFAF8D1FQ38303620-1EE19341-8005-4436-B781-B84328C8910DQ38736759-255CE593-7E7D-473F-805F-B1733B5006BBQ38832827-180827AB-69FB-404F-BDC1-40CD8C2AFF79Q40617722-319A2F6F-E1E0-4882-8A72-50209D0F8A13Q40833716-FBD861C1-E800-4459-A18D-82D5A8C0770BQ42588367-3BAD3C2C-5225-41C1-ADE4-4B800409D9CCQ42639607-35891CE7-A2B1-4D95-A98F-3F780E2EEAECQ49415841-99D7A219-C368-4974-AABB-C8A8AFFE3FE7Q51873286-AEAB51EF-9AEA-4252-95E6-148F4A20590D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic determinants of cardiac hypertrophy.
@en
Genetic determinants of cardiac hypertrophy.
@nl
type
label
Genetic determinants of cardiac hypertrophy.
@en
Genetic determinants of cardiac hypertrophy.
@nl
prefLabel
Genetic determinants of cardiac hypertrophy.
@en
Genetic determinants of cardiac hypertrophy.
@nl
P2860
P1476
Genetic determinants of cardiac hypertrophy.
@en
P2093
Ali J Marian
P2860
P304
P356
10.1097/HCO.0B013E3282FC27D9
P577
2008-05-01T00:00:00Z